Evidence map›Paper›PMID 29453744›Full record

ArticleJournal of clinical immunology2018

Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID).

Monica G Lawrence, Thamiris V Palacios-Kibler, Lisa J Workman, Alexander J Schuyler, John W Steinke, Spencer C Payne, Emily C McGowan, James Patrie, Ramsay L Fuleihan, Kathleen E Sullivan and 8 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03968211 (Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03968211 phase1completednot on this mapstarted 2019, after this paper: background citation

Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency

TypeinterventionalSponsorUniversity of VirginiaRan2019 to 2023Enrolled37ConditionsImmune DeficiencyArmsSalmonella typhi polysaccharide vaccine
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Functional testing of humoral immunity in the Prevnar 20 era.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2025
    Review
  5. IgE deficiency is not associated with hypogammaglobulinemia in a large cohort of military recruits.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 1 country.

Monica G LawrenceDepartment of Medicine, University of Virginia, Box 801355, Charlottesville, VA, 22908, USA. ml4nz@virginia.edu.ORCID 0000-0001-6450-3182
Thamiris V Palacios-KiblerDepartment of Medicine, University of Virginia, Box 801355, Charlottesville, VA, 22908, USA.
Lisa J WorkmanDepartment of Medicine, University of Virginia, Box 801355, Charlottesville, VA, 22908, USA.
Alexander J SchuylerDepartment of Medicine, University of Virginia, Box 801355, Charlottesville, VA, 22908, USA.
John W SteinkeDepartment of Medicine, University of Virginia, Box 801355, Charlottesville, VA, 22908, USA.
Spencer C PayneDepartment of Medicine, University of Virginia, Box 801355, Charlottesville, VA, 22908, USA.
Emily C McGowanDepartment of Medicine, University of Virginia, Box 801355, Charlottesville, VA, 22908, USA.
James PatrieDepartment of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
Ramsay L FuleihanAnn and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Kathleen E SullivanDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Patricia L LugarDepartment of Medicine, Duke University Health System, Durham, NC, USA.
Camellia L HernandezDivision of Allergy-Immunology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Douglas E BeakesDivision of Allergy-Immunology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
James W VerbskyDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Thomas A E Platts-MillsDepartment of Medicine, University of Virginia, Box 801355, Charlottesville, VA, 22908, USA.
Charlotte Cunningham-RundlesDepartment of Medicine and Pediatrics, Mount Sinai School of Medicine, New York, NY, USA.
John M RoutesDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Larry BorishDepartment of Medicine, University of Virginia, Box 801355, Charlottesville, VA, 22908, USA.
University of Virginia · USMedical College of Wisconsin · USWalter Reed National Military Medical Center · USCarter Center · USChildren's Hospital of Philadelphia · USDuke University Health System · USIcahn School of Medicine at Mount Sinai · USJohns Hopkins University · USLurie Children's Hospital · US

Funding

Regulation of IgA class switching in the intestinal mucosaP01AI061093 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CASANOVA, JEAN-LAURENT · 2004 to 2021
$29.8M
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory diseaseR37AI020565 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI THOMAS A. PLATTS-MILLS · 1992 to 2026
$8.4M
DUST MITE, COCKROACH AND CAT ALLERGENS IN HOUSES/ASTHMAR01AI020565 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI PLATTS-MILLS, THOMAS A. · 1985 to 2017
$7.1M
Resources to Assist Investigations in Primary Immunodeficiency Diseases (U24)U24AI086037 · NIAID · IMMUNE DEFICIENCY FOUNDATION · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2010 to 2019
$6.5M
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to aU01AI100799 · NIAID · UNIVERSITY OF VIRGINIA · PI HEYMANN, PETER W, PLATTS-MILLS, THOMAS A. · 2012 to 2015
$5.3M
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils iR01AI057438 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2006 to 2015
$3.7M
Clinical response to rhinovirus challenge in human asthmaticsU01AI123337 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2016 to 2020
$3.6M
Dietary Methyl Donors and Food Allergy Risk in the United StatesK23AI123596 · NIAID · UNIVERSITY OF VIRGINIA · PI MCGOWAN, EMILY CLARKE · 2017 to 2020
$767k
Clinical immune response to rhinovirus challenge in human asthmaticsR56AI120055 · NIAID · UNIVERSITY OF VIRGINIA · PI BORISH, LARRY C · 2015 to 2015
$386k
NIAID NIH HHS K23 AI123596NIAID NIH HHS P01 AI061093NIAID NIH HHS R01 AI020565NIAID NIH HHS R01 AI057438NIAID NIH HHS R37 AI020565NIAID NIH HHS R56 AI120055NIAID NIH HHS U01 AI100799NIAID NIH HHS U01 AI123337NIAID NIH HHS U24 AI086037
6 · The paper itself

Abstract

Although small prior studies have suggested that IgE can be low in common variable immunodeficiency (CVID), the workup for patients with recurrent infections and suspected hypogammaglobulinemia does not include the routine measurement of serum IgE. We sought to test the hypothesis that low/undetectable serum IgE is characteristic of CVID by comparing the frequency of low/undetectable serum IgE in healthy controls and patients with CVID. We measured total serum IgE in a large multi-center cohort of patients with CVID (n = 354) and compared this to large population-based cohorts of children and adults. We further compared IgE levels in patients with CVID to those with other forms of humoral immunodeficiency, and in a subset, measured levels of allergen-specific serum IgE and IgG subclasses. Lastly, we evaluated for the presence of IgE in commercially available immunoglobulin replacement therapy (IgRT) products. An undetectable serum IgE (< 2 IU/ml) occurs in only 3.3% (95% CI, 1.9-5.7%) of the general population. In contrast, an undetectable IgE occurs in 75.6% (95% CI, 65.6-85.7%) of patients with CVID. Conversely, a high IgE (> 180 IU/ml) is very uncommon in CVID (0.3% of patients). IgE is > 2 IU/ml in 91.2% of patients with secondary hypogammaglobulinemia, and thus, an IgE < LLOD is suggestive of a primary humoral immunodeficiency. Allergen-specific IgE is not detectable in 96.5% of patients with CVID. Sufficient quantities of IgE to change the total serum IgE are not contained in IgRT. The IgG1/IgG4 ratio is increased in subjects with low IgE, regardless of whether they are controls or have CVID. These findings support the routine measurement of serum IgE in the workup of patients with hypogammaglobulinemia.

Indexed as

BiomarkersAdolescentAdultAllergensChildCohort StudiesCommon Variable ImmunodeficiencyFemaleHumansImmunizationImmunoglobulin EImmunoglobulin GImmunoglobulin IsotypesMaleSensitivity and SpecificityYoung AdultAllergensBiomarkersImmunoglobulin EImmunoglobulin GImmunoglobulin IsotypesCommon variable immunodeficiencyIgEIgE deficiencysecondary hypogammaglobulinemia

Identifiers

PMID29453744
PMCPMC5934300
OpenAlexW2793638997

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.